Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Wajeeh Khan

Should You Buy HIMS Stock Following Friday's Rally?

Investors have piled into Hims & Hers Health (HIMS) shares in recent sessions on the back of a key regulatory update and a bullish research report from JPMorgan. 

The recent momentum has helped HIMS rip through its major moving averages (MAs), signaling that the bulls are now taking back control across multiple timeframes. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.